Mesenchymal stem cells: No longer second class marrow citizens
Stanton L. Gerson
Division of Hematology/Oncology Ireland Cancer Center
at Case Western Reserve University University Hospitals of Cleveland
Cleveland, Ohio 44106, USA
slg5@po.cwru.edu
Osteogenesis Imperfeca study raises new hopes and questions for
mesenchymal and stem cell therapies (pages 309−313).